GlassScriptPhysician profile
Robert L Humble
NPI 1285665554
$2,646.62
in general payments reported to CMS, 2019-2025
26 companies · $18.30 in 2025
The $18.30 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $188 · 2021: $787 · 2022: $607 · 2023: $472 · 2024: $378 · 2025: $18.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $959.23 | 2019-2024 | Veozah, Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $293.01 | 2022-2024 | Erleada, Akeega |
| Pfizer INC. | $220.44 | 2019-2023 | |
| Urovant Sciences INC | $157.52 | 2021-2022 | |
| Antares Pharma, INC. | $124.48 | 2021-2024 | Xyosted |
| Coloplast Corp | $107.34 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $93.45 | 2019-2023 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $84.47 | 2022-2024 | |
| Axonics, INC. | $78.69 | 2020-2024 | Bulkamid |
| Rochester Medical Corporation | $70.27 | 2019-2022 | |
| Allergan, INC. | $63.69 | 2021 | |
| Teleflex LLC | $49.47 | 2021 | |
| Hollister Incorporated | $40.20 | 2022-2023 | Infyna Chic |
| Tolmar, INC. | $37.10 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $35.62 | 2023 | Gemtesa |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $33.41 | 2023-2024 | Pylarify |
| Boston Scientific Corporation | $29.27 | 2023 | Rezum Generator |
| C. R. Bard, INC. & Subsidiaries | $27.03 | 2019 | |
| Laborie Medical Technologies Corp. | $23.96 | 2023 | |
| Endo USA, INC. | $18.63 | 2024 | Xiaflex |
| Novo Nordisk INC | $18.30 | 2025 | Wegovy |
| Abbvie INC. | $17.12 | 2022 | |
| Amgen INC. | $16.82 | 2023 | Prolia |
| Neotract INC. | $16.51 | 2020 | |
| Therapeuticsmd, INC. | $15.48 | 2019 | |
| Abc Home Medical Supply, INC. | $15.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Humble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.